Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/03/050707
CTRI/2023/03/050707
Not yet recruiting
未知

Factors Predicting Hospital Revisit and Rehospitalization Within Two Weeks Following Percutaneous Nephrolithotomy- A Prospective Observational Study

MAHE0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: N00-N99- Diseases of the genitourinary system

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Sponsor
MAHE
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
MAHE

Eligibility Criteria

Inclusion Criteria

  • •1\.Patient aged \> 18years admitted with diagnosis of renal calculi.
  • •2\.Patient who have revisited hospital within 14 days due to symptoms related to the procedure from the date of discharge.
  • •3\.Patients readmitted within 14 days due to symptoms related to the procedure from the
  • •date of discharge

Exclusion Criteria

  • •1\.Patient readmitted due to other cause or symptoms not related to PCNL complications.
  • •2\.Patient readmitted beyond 14 days from date of discharge

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Reasons for Hospital Revist and Rehospitalization Following URSL - A PROSPECTIVE OBSERVATIONAL STUDYHealth Condition 1: N00-N99- Diseases of the genitourinary system
CTRI/2023/04/051246MAHE
Active, not recruiting
Not Applicable
sing artificial intelligence as an aid to predict the risk of hospital readmission in patients with COVID-19COVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN85858267niversity of Edinburgh5,261
Completed
Not Applicable
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post ExacerbationPulmonary Disease, Chronic Obstructive
NCT01381458GlaxoSmithKline1,936
Completed
Not Applicable
Identifying Factors Influencing In-Hospital Relapse in Pemphigus PatientsPemphigus Vulgaris
NCT06167408First Affiliated Hospital of Chongqing Medical University96
Recruiting
Not Applicable
Clinical evaluation of time to re-hospitalization and renal function of tolvaptan in congestive heart failure patients with volume overload. Prospective randomized controlled trial.congestive heart failure
JPRN-UMIN000009810Saiseikai Noe hospital180